TrialInvestigational new drugs2020

Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma.

Antje Wick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.